Please login to the form below
Q1
This page shows the latest Q1 news and features for those working in and with pharma, biotech and healthcare.
bluebird bio shares therapy updates for 2022
company is reinforcing its plans to submit the Biologics License Application (BLA) for lovo-cel in Q1 2023.
Latest news
-
AZ raises full-year guidance after completing Alexion acquisition in Q2
Sales of its COVID-19 vaccine – sold under the Vaxzevria brand name in Europe – reached $894m in Q2, up from Q1 sales of $275m.
-
US pauses shipments of Eli Lilly’s COVID-19 antibody treatment due to variant concerns
In Q1, the total revenue for Lilly’s COVID-19 antibodies was $650.6m in the US and $159.5m elsewhere.
-
Developers of COVID-19 vaccines and therapeutics highlight continued need for treatments
In Q1, Regeneron recorded US net sales of $262m for REGEN-COV under its first contract with the US government.
-
bluebird bio aiming to separate business units by year-end
Amid the biotech company’s Q1 results, bluebird bio revealed the new company’s name – 2seventy bio. ... Research and development expenses for Q1 were also up slightly, increasing from $154.1m last year to $154.5 in 2021.
-
BioNTech on course to produce three billion doses of Pfizer-partnered COVID-19 vaccine in 2021
The German biotech company also previously raised the full-year manufacturing capacity target for the vaccine from 2 billion to 2.5 billion doses during its Q1 results. ... During Pfizer's Q1 earnings presentation, the company said that it expects to
More from news
Approximately 12 fully matching, plus 172 partially matching documents found.
Latest Intelligence
-
Setting up for success in a post-Brexit, post-pandemic Britain
Creating a new biotech affiliate and seeking marketing authorisation for a new drug in the UK during a pandemic
-
Medicinal data – what’s next for IDMP?
This guidance is expected to be published by Q1 2021. The clock will then start ticking towards SPOR data-based submissions: these will be possible within 12 months, and become mandatory ... That might sound like it is a fair way off, but the fact that
-
The ‘blueprint’ for MSL success is changing
The EU MSL Academy programme and MSL Excellence Framework will go live in Q1 2020.
-
Biotech profile: Tom Evans, CEO, Vaccitech.
VACCITECH'S PIPELINE. VTP-100's clinical phase 2b trial is just getting underway, with analysis of the clinical and virologic data by Q1 2020.
-
M&A drivers in healthcare communications
trend looks set to continue in 2019 with eight transactions having taken place in Q1 already.
More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.
Latest appointments
-
Penn Pharma appoints Carlo Truppi to drive US business
He joins the manufacturing firm from Bilcare Global Clinical Supplies
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
After a busy first quarter, emotive welcomes five new team members
We’re well into 2019 and with Q1 complete, the year is shaping up to be one of our busiest yet.
-
News: Therapy Watch launches a new wave of EU tracking in Psoriasis (PsO)
In addition from Q1 2019 Therapy Watch will now be tracking prescription topical treatments in both a secondary care and primary care setting providing broad visibility of the psoriasis market landscape.
-
Blue Latitude Health hires 7 new members of staff in 2016 Q1
Blue Latitude Health has added seven new full time members of staff in the first quarter of 2016. 2016 has been a year of growth at Blue Latitude Health. And as our teams grow and evolve, we’d like to take some time to shine a spotlight on the
-
Measurement and optimisation for digital marketing success in the pharmaceutical industry
Increase new users of an HCP portal by 1, 500 in Q1.
-
Framing, provocation, and truth
That is,. e.g. Q1 (Frame 1) results vs Q1 (Frame 2) results – discuss,.
More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- My journey advancing the science in pulmonary hypertension
- NHS App to revolutionise digital health and care with major digital updates by 2023
- A new era for UK-Japanese scientific research relations
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- New Omicron sub-variants cause COVID-19 cases to rise in the UK
- Novartis announces positive phase 3 trial results for advanced oesophageal cancer
- Sanofi Global Health unveils new nonprofit Impact brand
- Pfizer announces commitment to achieve Net-Zero Standard by 2040
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- A creative awakening – how pharma is bringing innovation to the patient journey
- Behaviour change – a maze of decisions influenced by personal habits, experiences and intentions
- My journey advancing the science in pulmonary hypertension
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine
- Delivering content to fuel omnichannel engagement
PMHub
Lucid Group Communications Limited
WE’RE ON A MISSION
To transform lives through communication that changes behaviour and improves health outcomes....
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
